Department of Health, Exercise, and Sport Science, University of New Mexico, Albuquerque, New Mexico;
J Appl Physiol (1985). 2014 Jan 15;116(2):183-91. doi: 10.1152/japplphysiol.00646.2013. Epub 2013 Nov 27.
The objectives of this study are threefold: 1) to assess whether 7 days of oral glutamine (GLN) supplementation reduces exercise-induced intestinal permeability; 2) whether supplementation prevents the proinflammatory response; and 3) whether these changes are associated with upregulation of the heat shock response. On separate occasions, eight human subjects participated in baseline testing and in GLN and placebo (PLA) supplementation trials, followed by a 60-min treadmill run. Intestinal permeability was higher in the PLA trial compared with baseline and GLN trials (0.0604 ± 0.047 vs. 0.0218 ± 0.008 and 0.0272 ± 0.007, respectively; P < 0.05). IκBα expression in peripheral blood mononuclear cells was higher 240 min after exercise in the GLN trial compared with the PLA trial (1.411 ± 0.523 vs. 0.9839 ± 0.343, respectively; P < 0.05). In vitro using the intestinal epithelial cell line Caco-2, we measured effects of GLN supplementation (0, 4, and 6 mM) on heat-induced (37° or 41.8°C) heat shock protein 70 (HSP70), heat shock factor-1 (HSF-1), and occludin expression. HSF-1 and HSP70 levels increased in 6 mM supplementation at 41°C compared with 0 mM at 41°C (1.785 ± 0.495 vs. 0.6681 ± 0.290, and 1.973 ± 0.325 vs. 1.133 ± 0.129, respectively; P < 0.05). Occludin levels increased after 4 mM supplementation at 41°C and 6 mM at 41°C compared with 0 mM at 41°C (1.236 ± 0.219 and 1.849 ± 0.564 vs. 0.7434 ± 0.027, respectively; P < 0.001). GLN supplementation prevented exercise-induced permeability, possibly through HSF-1 activation.
1)评估口服谷氨酰胺(GLN)补充 7 天是否能降低运动引起的肠道通透性;2)补充是否能阻止促炎反应;3)这些变化是否与热休克反应的上调有关。在不同的时间点,8 名受试者分别参加了基础测试、GLN 和安慰剂(PLA)补充试验,然后进行 60 分钟的跑步机跑步。与基础测试和 GLN 试验相比,PLA 试验中的肠道通透性更高(0.0604±0.047 比 0.0218±0.008 和 0.0272±0.007,分别;P<0.05)。GLN 试验中,运动后 240 分钟外周血单核细胞中的 IκBα 表达高于 PLA 试验(1.411±0.523 比 0.9839±0.343,分别;P<0.05)。在体外使用肠上皮细胞系 Caco-2,我们测量了 GLN 补充(0、4 和 6 mM)对热诱导(37°C 或 41.8°C)热休克蛋白 70(HSP70)、热休克因子-1(HSF-1)和闭合蛋白表达的影响。与 0 mM 在 41°C 相比,6 mM 在 41°C 时 HSF-1 和 HSP70 水平升高(1.785±0.495 比 0.6681±0.290,和 1.973±0.325 比 1.133±0.129,分别;P<0.05)。与 0 mM 在 41°C 相比,4 mM 在 41°C 和 6 mM 在 41°C 时闭合蛋白水平升高(1.236±0.219 和 1.849±0.564 比 0.7434±0.027,分别;P<0.001)。GLN 补充可预防运动引起的通透性,可能通过 HSF-1 激活。